American Vanguard Corp (AVD)

$11.09

-0.18

(-1.6%)

Market is closed - opens 7 PM, 19 Apr 2024

Insights on American Vanguard Corp

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 124.88M → 172.18M (in $), with an average increase of 10.1% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -1.05M → 6.97M (in $), with an average increase of 164.3% per quarter

  • Vs CF

    In the last 1 year, Cf Industries Holdings, Inc. has given 3.7% return, outperforming this stock by 50.5%

  • Vs CF

    In the last 3 years, Cf Industries Holdings, Inc. has given 64.4% return, outperforming this stock by 108.9%

Performance

  • $11.09
    $11.39
    $11.09
    downward going graph

    0.0%

    Downside

    Day's Volatility :2.63%

    Upside

    2.63%

    downward going graph
  • $8.37
    $20.85
    $11.09
    downward going graph

    24.53%

    Downside

    52 Weeks Volatility :59.86%

    Upside

    46.81%

    downward going graph

Returns

PeriodAmerican Vanguard CorpSector (Materials)Index (Russel 2000)
3 Months
15.83%
8.3%
0.0%
6 Months
9.84%
15.4%
0.0%
1 Year
-46.84%
8.9%
-1.5%
3 Years
-44.67%
7.7%
-21.8%

Highlights

Market Capitalization
334.3M
Book Value
$12.87
Dividend Share
0.12
Dividend Yield
1.03%
Earnings Per Share (EPS)
0.26
PE Ratio
44.62
PEG Ratio
2.27
Wall Street Target Price
18.0
Profit Margin
1.3%
Operating Margin TTM
7.02%
Return On Assets TTM
1.95%
Return On Equity TTM
2.03%
Revenue TTM
579.4M
Revenue Per Share TTM
20.6
Quarterly Revenue Growth YOY
7.9%
Gross Profit TTM
241.4M
EBITDA
46.8M
Diluted Eps TTM
0.26
Quarterly Earnings Growth YOY
0.78
EPS Estimate Current Year
0.77
EPS Estimate Next Year
0.85
EPS Estimate Current Quarter
0.27
EPS Estimate Next Quarter
0.07

Analyst Recommendation

Buy
    83%Buy
    16%Hold
    0
    0%Sell
Based on 6 Wall street analysts offering stock ratings for American Vanguard Corp(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
4
5
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 62.31%

Current $11.09
Target $18.00

Company Financials

FY18Y/Y Change
Revenue
454.3M
↑ 27.95%
Net Income
24.2M
↑ 19.34%
Net Profit Margin
5.33%
↓ 0.38%
FY19Y/Y Change
Revenue
468.2M
↑ 3.06%
Net Income
13.6M
↓ 43.79%
Net Profit Margin
2.91%
↓ 2.42%
FY20Y/Y Change
Revenue
458.7M
↓ 2.03%
Net Income
15.2M
↑ 12.07%
Net Profit Margin
3.32%
↑ 0.41%
FY21Y/Y Change
Revenue
556.9M
↑ 21.4%
Net Income
18.6M
↑ 21.95%
Net Profit Margin
3.34%
↑ 0.02%
FY22Y/Y Change
Revenue
609.6M
↑ 9.47%
Net Income
27.4M
↑ 47.44%
Net Profit Margin
4.5%
↑ 1.16%
FY23Y/Y Change
Revenue
579.4M
↓ 4.96%
Net Income
7.5M
↓ 72.56%
Net Profit Margin
1.3%
↓ 3.2%
Q3 FY22Q/Q Change
Revenue
152.1M
↑ 2.72%
Net Income
6.7M
↓ 1.3%
Net Profit Margin
4.43%
↓ 0.18%
Q4 FY22Q/Q Change
Revenue
160.0M
↑ 5.17%
Net Income
3.9M
↓ 42.17%
Net Profit Margin
2.44%
↓ 1.99%
Q1 FY23Q/Q Change
Revenue
124.9M
↓ 21.94%
Net Income
1.9M
↓ 50.8%
Net Profit Margin
1.54%
↓ 0.9%
Q2 FY23Q/Q Change
Revenue
132.8M
↑ 6.33%
Net Income
-1.1M
↓ 154.9%
Net Profit Margin
-0.79%
↓ 2.33%
Q3 FY23Q/Q Change
Revenue
149.5M
↑ 12.6%
Net Income
-325.0K
↓ 69.14%
Net Profit Margin
-0.22%
↑ 0.57%
Q4 FY23Q/Q Change
Revenue
172.2M
↑ 15.16%
Net Income
7.0M
↓ 2247.38%
Net Profit Margin
4.05%
↑ 4.27%
FY18Y/Y Change
Total Assets
593.6M
↑ 10.83%
Total Liabilities
264.4M
↑ 14.8%
FY19Y/Y Change
Total Assets
670.1M
↑ 12.89%
Total Liabilities
325.9M
↑ 23.3%
FY20Y/Y Change
Total Assets
667.2M
↓ 0.43%
Total Liabilities
306.4M
↓ 5.98%
FY21Y/Y Change
Total Assets
694.2M
↑ 4.04%
Total Liabilities
321.4M
↑ 4.89%
FY22Y/Y Change
Total Assets
726.3M
↑ 4.63%
Total Liabilities
356.3M
↑ 10.86%
FY23Y/Y Change
Total Assets
799.4M
↑ 10.06%
Total Liabilities
429.4M
↑ 20.5%
Q3 FY22Q/Q Change
Total Assets
776.2M
↑ 4.37%
Total Liabilities
413.6M
↑ 15.27%
Q4 FY22Q/Q Change
Total Assets
726.3M
↓ 6.42%
Total Liabilities
356.3M
↓ 13.85%
Q1 FY23Q/Q Change
Total Assets
771.1M
↑ 6.16%
Total Liabilities
396.1M
↑ 11.15%
Q2 FY23Q/Q Change
Total Assets
772.7M
↑ 0.21%
Total Liabilities
403.6M
↑ 1.89%
Q3 FY23Q/Q Change
Total Assets
802.8M
↑ 3.91%
Total Liabilities
444.1M
↑ 10.05%
Q4 FY23Q/Q Change
Total Assets
799.4M
↓ 0.43%
Total Liabilities
429.4M
↓ 3.33%
FY18Y/Y Change
Operating Cash Flow
11.3M
↓ 80.77%
Investing Cash Flow
-27.7M
↓ 69.06%
Financing Cash Flow
11.1M
↓ 67.19%
FY19Y/Y Change
Operating Cash Flow
9.4M
↓ 17.12%
Investing Cash Flow
-54.8M
↑ 97.99%
Financing Cash Flow
46.4M
↑ 316.83%
FY20Y/Y Change
Operating Cash Flow
89.2M
↑ 848.6%
Investing Cash Flow
-35.8M
↓ 34.72%
Financing Cash Flow
-43.2M
↓ 193.12%
FY21Y/Y Change
Operating Cash Flow
87.3M
↓ 2.11%
Investing Cash Flow
-20.0M
↓ 44.01%
Financing Cash Flow
-65.9M
↑ 52.44%
FY22Y/Y Change
Operating Cash Flow
57.1M
↓ 34.6%
Investing Cash Flow
-14.5M
↓ 27.8%
Financing Cash Flow
-38.3M
↓ 41.92%
Q3 FY22Q/Q Change
Operating Cash Flow
-18.4M
↓ 462.79%
Investing Cash Flow
-3.3M
↑ 36.6%
Financing Cash Flow
19.8M
↑ 666.87%
Q4 FY22Q/Q Change
Operating Cash Flow
102.8M
↓ 657.15%
Investing Cash Flow
-4.5M
↑ 35.83%
Financing Cash Flow
-98.1M
↓ 595.99%
Q1 FY23Q/Q Change
Operating Cash Flow
-41.5M
↓ 140.33%
Investing Cash Flow
-3.3M
↓ 26.36%
Financing Cash Flow
43.8M
↓ 144.64%
Q2 FY23Q/Q Change
Operating Cash Flow
-55.2M
↑ 33.05%
Investing Cash Flow
-7.2M
↑ 116.81%
Financing Cash Flow
54.3M
↑ 24.06%
Q3 FY23Q/Q Change
Operating Cash Flow
-49.3M
↓ 10.69%
Investing Cash Flow
-9.1M
↑ 27.55%
Financing Cash Flow
48.6M
↓ 10.52%

Technicals Summary

Sell

Neutral

Buy

American Vanguard Corp is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
American Vanguard Corp
American Vanguard Corp
-3.59%
9.84%
-46.84%
-44.67%
-35.67%
Fmc Corp.
Fmc Corp.
-15.14%
-15.27%
-55.04%
-50.31%
-29.88%
Nutrien Ltd.
Nutrien Ltd.
-3.72%
-15.55%
-29.9%
-3.97%
-4.09%
Corteva, Inc.
Corteva, Inc.
-2.16%
4.49%
-14.99%
12.65%
84.59%
Cf Industries Holdings, Inc.
Cf Industries Holdings, Inc.
-9.51%
-8.19%
3.65%
65.85%
72.35%
Mosaic Company, The
Mosaic Company, The
-5.99%
-17.42%
-34.49%
-7.45%
11.9%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
American Vanguard Corp
American Vanguard Corp
44.62
44.62
2.27
0.77
0.02
0.02
0.01
12.87
Fmc Corp.
Fmc Corp.
4.9
4.9
1.85
3.79
0.36
0.04
0.04
35.35
Nutrien Ltd.
Nutrien Ltd.
20.42
20.42
NA
3.95
0.05
0.04
0.04
50.87
Corteva, Inc.
Corteva, Inc.
41.02
41.02
2.35
2.83
0.04
0.03
0.01
35.7
Cf Industries Holdings, Inc.
Cf Industries Holdings, Inc.
9.92
9.92
0.64
6.12
0.23
0.1
0.03
30.38
Mosaic Company, The
Mosaic Company, The
8.69
8.69
0.2
3.04
0.1
0.03
0.03
37.92
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
American Vanguard Corp
American Vanguard Corp
Buy
$334.3M
-35.67%
44.62
1.3%
Fmc Corp.
Fmc Corp.
Buy
$7.1B
-29.88%
4.9
29.45%
Nutrien Ltd.
Nutrien Ltd.
Buy
$25.9B
-4.09%
20.42
4.48%
Corteva, Inc.
Corteva, Inc.
Buy
$37.3B
84.59%
41.02
4.27%
Cf Industries Holdings, Inc.
Cf Industries Holdings, Inc.
Buy
$14.7B
72.35%
9.92
23.0%
Mosaic Company, The
Mosaic Company, The
Hold
$9.8B
11.9%
8.69
8.51%

Institutional Holdings

  • BlackRock Inc

    7.49%
  • Dimensional Fund Advisors, Inc.

    6.97%
  • Wellington Management Company LLP

    5.86%
  • Vanguard Group Inc

    5.57%
  • Cruiser Capital Advisors, LLC

    3.37%
  • Millennium Management LLC

    3.31%

Corporate Announcements

  • American Vanguard Corp Dividends March,2024

    In the quarter ending March,2024. American Vanguard Corp has declared dividend of $0.03

    Read More

Company Information

american vanguard corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the united states and internationally. the company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. it also markets and distributes end-use chemical and biological products for crop applications; distributes chemicals for greenhouse and nursery production markets; and offers formulations, such as pcnb, chlorothalonil, and propiconazole under the ffii and ffiii names. the company distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. american vanguard corporation was founded in 196

Organization
American Vanguard Corp
Employees
845
CEO
Mr. Eric G. Wintemute
Industry
Process Industries

FAQs